BIOLINERX LTD's ticker is BLRXXXXX and the CUSIP is 09071M106. A total of 30 filers reported holding BIOLINERX LTD in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $95,000 | -72.1% | 86,759 | -79.6% | 0.00% | -100.0% |
| Q2 2016 | $340,000 | -33.3% | 425,000 | -15.0% | 0.00% | 0.0% |
| Q1 2016 | $510,000 | -34.6% | 500,000 | -16.7% | 0.00% | -50.0% |
| Q4 2015 | $780,000 | -15.0% | 600,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $918,000 | -40.7% | 600,000 | +3.0% | 0.00% | -33.3% |
| Q2 2015 | $1,549,000 | +68.0% | 582,361 | +33.3% | 0.00% | +50.0% |
| Q1 2015 | $922,000 | – | 436,917 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 17,500,000 | $14,875,000 | 2.31% |
| DAFNA Capital Management LLC | 980,352 | $828,000 | 0.59% |
| Senvest Management, LLC | 7,781,641 | $6,575,000 | 0.52% |
| SABBY MANAGEMENT, LLC | 2,949,051 | $2,507,000 | 0.16% |
| Benchmark Capital Advisors | 144,000 | $122,000 | 0.10% |
| Opaleye Management Inc. | 250,000 | $212,000 | 0.09% |
| Cutter & CO Brokerage, Inc. | 31,000 | $26,000 | 0.01% |
| NEXT Financial Group, Inc | 41,500 | $35,000,000 | 0.01% |
| Orbimed Advisors | 1,038,600 | $878,000 | 0.01% |
| Harel Insurance Investments & Financial Services Ltd. | 108,000 | $91,000 | 0.01% |